UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Paradigm shift in the treatment options of hepatocellular carcinoma

Liver international, 2022-08, Vol.42 (9), p.2067-2079

2022

Volltextzugriff (PDF)

Artificial intelligence in precision medicine in hepatology

Journal of gastroenterology and hepatology, 2021-03, Vol.36 (3), p.569-580

2021

Volltextzugriff (PDF)

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg‐negative chronic hepatitis B

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.415-424

2018

Volltextzugriff (PDF)

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Liver international, 2016-12, Vol.36 (12), p.1755-1764

2016

Volltextzugriff (PDF)

Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2019-01, Vol.69 (1), p.209-221

2019

Volltextzugriff (PDF)

The clinical manifestations and management of COVID-19-related liver injury

Journal of the Formosan Medical Association, 2020-06, Vol.119 (6), p.1016-1018

2020

Volltextzugriff (PDF)

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.1140-1149.e3

2012

Volltextzugriff (PDF)

Anti‐HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B

Liver international, 2023-04, Vol.43 (4), p.947-948

2023

Volltextzugriff (PDF)

Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling

Gut, 2022-09, Vol.71 (9), p.1876-1891

2022

Volltextzugriff (PDF)

Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review

Journal of the Formosan Medical Association, 2024-08, Vol.123 (8), p.916-919

2024

Volltextzugriff (PDF)

Reply to comment on “Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection”

Journal of the Formosan Medical Association, 2024-06, Vol.123 (6), p.725-726

2024

Volltextzugriff (PDF)

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals

Journal of hepatology, 2020-05, Vol.72 (5), p.839-846

2020

Volltextzugriff (PDF)

Real‐world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan

Liver international, 2023-11, Vol.43 (11), p.2404-2414

2023

Volltextzugriff (PDF)

Unmet Needs in Clinical and Basic Hepatitis B Virus Research

The Journal of infectious diseases, 2017-11, Vol.216 (suppl_8), p.S750-S756

2017

Volltextzugriff (PDF)

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.441-450

2013

Volltextzugriff (PDF)

Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load

Alimentary pharmacology & therapeutics, 2021-04, Vol.53 (8), p.908-918

2021

Volltextzugriff (PDF)

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Gut and Liver, 2021, 15(3), , pp.451-458

2021

Volltextzugriff (PDF)

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping

Journal of medical virology, 2024-05, Vol.96 (5), p.e29686-n/a

2024

Volltextzugriff (PDF)

Chronic hepatitis B is associated with an increased risk of B‐cell non‐Hodgkin's lymphoma and multiple myeloma

Alimentary pharmacology & therapeutics, 2019-03, Vol.49 (5), p.589-598

2019

Volltextzugriff (PDF)

APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients

Hepatology international, 2021-08, Vol.15 (4), p.833-851

2021

Volltextzugriff (PDF)

HCC risk in patients with HBV‐related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1634-1635

2018

Volltextzugriff (PDF)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective

Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.230-241

2023

Volltextzugriff (PDF)

Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level

Scientific reports, 2022-04, Vol.12 (1), p.5799-5799, Article 5799

2022

Volltextzugriff (PDF)

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy

The Journal of infectious diseases, 2020-01, Vol.221 (3), p.389-399

2020

Volltextzugriff (PDF)

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.68-76

2012

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(192)
Life Sciences & Biomedicine
(170)
Humans
(121)
Gastroenterology & Hepatology
(90)
Male
(75)
Female
(73)
Middle Aged
(66)
Adult
(65)
Hepatitis B
(60)
Hepatitis
(56)
Antiviral Agents - Therapeutic Use
(49)
Hepatitis B Virus
(45)
Hepatitis C
(36)
Aged
(35)
Liver Cancer
(35)
Interferon
(34)
Hepatitis C Virus
(33)
Hepatitis B, Chronic - Drug Therapy
(32)
Hepatocellular Carcinoma
(31)
Hepatology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Paradigm shift in the treatment options of hepatocellular carcinoma

Artificial intelligence in precision medicine in hepatology

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg‐negative chronic hepatitis B

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma

The clinical manifestations and management of COVID-19-related liver injury

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

Anti‐HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B

Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling

Progression of portal hypertension after atezolizumab plus bevacizumab for hepatocellular carcinoma-report a case and literature review

Reply to comment on “Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection”

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals

Real‐world epidemiology, treatment patterns and disease burden of patients diagnosed with chronic hepatitis B in Taiwan

Unmet Needs in Clinical and Basic Hepatitis B Virus Research

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping

Chronic hepatitis B is associated with an increased risk of B‐cell non‐Hodgkin's lymphoma and multiple myeloma

APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients

HCC risk in patients with HBV‐related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective

Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load

Suchergebnisse filtern